AR Bahadori, P Javadnia, S Dahaghin… - Neurosurgical …, 2024 - Springer
Abstract Background Deep Brain Stimulation (DBS) is FDA-approved for several movement disorders; such as Parkinson's disease, dystonia, and neuropsychiatric disorders. There are …
J Steinhardt, L Lokowandt, D Rasche, A Koch… - Scientific Reports, 2023 - nature.com
Body weight gain in combination with metabolic alterations has been observed after deep brain stimulation (DBS) of subthalamic nucleus (STN) in patients with Parkinson's disease …
Abstract Background Weight loss in Parkinson's disease (PD) is common and associated with increased mortality. The clinical significance of weight changes following deep brain …
RM Fernández, EN Villalba… - Journal of Neurology …, 2024 - jnnp.bmj.com
Background Unilateral focused ultrasound subthalamotomy (FUS-STN) improves motor features of Parkinson's disease (PD) in moderately advanced patients. The less invasive …
Depression in Parkinson's disease (PD) is common, disabling and has poor outcomes. Dopamine has a well-established role in both reward and motivational pathways. The …
Deep brain stimulation (DBS) is a neurosurgical treatment that involves electrically stimulating brain structures through stereotactically implanted electrodes. While it is …
GM Meyer, G Lio, M Albares, A Beliakova… - … des troubles de l' … - theses.hal.science
As an input station of the basal ganglia, the subthalamic nucleus is a key component of the different cortico-basal networks involved in movement control. Subthalamic deep brain …
Parkinson's disease (PD) is a neurodegenerative disorder that affects about 1% of people aged over sixty. Although PD is considered a movement disorder, psychiatric symptoms …